US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

13.87

+0.79006.04%

Post-market: 13.870.00000.00%16:49 EST

Volume:1.10M

Turnover:14.98M

Market Cap:610.62M

PE:-7.84

High:14.04

Open:13.69

Low:12.71

Close:13.08

52wk High:32.71

52wk Low:8.89

Shares:44.02M

Float Shares:23.70M

Volume Ratio:0.92

T/O Rate:4.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7690

EPS(LYR):-8.6026

ROE:-47.52%

ROA:-20.08%

PB:2.07

PE(LYR):-1.61

Loading ...

Overview Company News Filings

UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target

MT Newswires Live

Beta Bionics initiated with a Buy at UBS

Beta Bionics Is Maintained at Buy by Stifel

U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico

Lake Street Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)

Balanced Risk-Reward Amid FDA Warning Letter Keeps Beta Bionics at Hold

Beta Bionics discloses FDA warning letter

Beta Bionics price target lowered to $25 from $37 at Truist

Beta Bionics Is Maintained at Buy by Truist Securities

Truist Trims Price Target on Beta Bionics to $25 From $37, Keeps Buy Rating

MT Newswires Live

U.S. RESEARCH ROUNDUP-Air Products, Chevron, UnitedHealth

Beta Bionics Inc - Warning Letter Does Not Restrict Production or FDA Clearance - SEC Filing

THOMSON REUTERS

FDA Issues Warning Letter to Beta Bionics Over Quality System Deficiencies

Beta Bionics Initiated at Hold by TD Cowen

TD Cowen Initiates Beta Bionics at Hold WIth Price Target $17

MT Newswires Live

U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings

Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026

Beta Bionics price target lowered to $25 from $33 at Goldman Sachs

Beta Bionics Slides After Preliminary Key Indicator Falls Short

Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":13.87,"timestamp":1770670800000,"preClose":13.08,"halted":0,"volume":1096694,"hourTrading":{"tag":"盘后","latestPrice":13.87,"preClose":13.87,"latestTime":"16:49 EST","volume":13388,"amount":185697.51766,"timestamp":1770673781217,"change":0,"changeRate":0,"amplitude":0.00721},"delay":0,"changeRate":0.060397553516819504,"floatShares":23702000,"shares":44024631,"eps":-1.769,"marketStatus":"Post-Mkt","change":0.79,"latestTime":"02-09 18:48:11 EST","open":13.69,"high":14.04,"low":12.71,"amount":14977594.922454,"amplitude":0.101682,"askPrice":15.28,"askSize":100,"bidPrice":13.68,"bidSize":93,"shortable":3,"etf":0,"ttmEps":-1.769,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":13.08,"preHourTrading":{"tag":"盘前","latestPrice":13.66,"preClose":13.08,"latestTime":"09:29 EST","volume":1740,"amount":23587.6401,"timestamp":1770647369049,"change":0.58,"changeRate":0.044343,"amplitude":0.037462},"postHourTrading":{"tag":"盘后","latestPrice":13.87,"preClose":13.87,"latestTime":"16:49 EST","volume":13388,"amount":185697.51766,"timestamp":1770673781217,"change":0,"changeRate":0,"amplitude":0.00721},"volumeRatio":0.919845,"impliedVol":0.6049,"impliedVolPercentile":0.25},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":23702000,"roa":"-20.08%","roe":"-47.52%","lyrEps":-8.602584,"volumeRatio":0.919845,"shares":44024631,"dividePrice":0,"high":14.04,"amplitude":0.101682,"preClose":13.08,"low":12.71,"week52Low":8.89,"pbRate":"2.07","psRate":"6.89","week52High":32.71,"institutionHeld":0,"latestPrice":13.87,"committee":-0.036269,"eps":-1.769,"divideRate":0,"volume":1096694,"delay":0,"ttmEps":-1.769,"open":13.69,"prevYearClose":30.47,"prevWeekClose":13.08,"prevMonthClose":13.83,"prevQuarterClose":30.47,"fiveDayClose":13.7,"twentyDayClose":20.14,"sixtyDayClose":28.82,"earningDate":1771257600000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"date":"2026-02-17","symbol":"BBNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"defaultRemindTime":1771362000000,"name":null,"time":"Post Market","dateTimestamp":1771304400000,"actualEps":null},{"market":"US","date":"2026-01-08","symbol":"BBNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767848400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"BBNX","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-07-29","symbol":"BBNX","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-05-06","symbol":"BBNX","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.3636,"hold":0.2727,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1769490000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2026-02-06","current":-7.840588,"percent":0.992218,"low":-18.401318,"twenty":-15.977182,"median":-11.659491,"eighty":-8.794306,"high":-3.90273,"avg":-12.120407,"sd":3.340895,"marketCap":582886114},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-25","current":-8.755902,"twenty":-16.843777,"median":-12.117325,"eighty":-8.660901,"marketCap":479438170},{"date":"2025-05-02","current":-8.819236,"twenty":-16.797439,"median":-11.630778,"eighty":-8.660901,"marketCap":482906077},{"date":"2025-05-09","current":-9.109566,"twenty":-16.202771,"median":-11.468596,"eighty":-8.660901,"marketCap":646442149},{"date":"2025-05-16","current":-8.41306,"twenty":-16.195048,"median":-11.020664,"eighty":-8.526317,"marketCap":597015989},{"date":"2025-05-23","current":-9.476148,"twenty":-16.117818,"median":-10.030495,"eighty":-8.550067,"marketCap":672455918},{"date":"2025-05-30","current":-9.384503,"twenty":-15.951002,"median":-9.677769,"eighty":-8.619734,"marketCap":665952476},{"date":"2025-06-06","current":-11.944468,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"marketCap":847615293},{"date":"2025-06-13","current":-11.90781,"twenty":-15.527784,"median":-10.843036,"eighty":-8.663027,"marketCap":845013916},{"date":"2025-06-20","current":-10.863051,"twenty":-15.401128,"median":-10.973025,"eighty":-8.671464,"marketCap":770874676},{"date":"2025-06-27","current":-9.158444,"twenty":-15.033515,"median":-10.853044,"eighty":-8.690985,"marketCap":649910652},{"date":"2025-07-03","current":-8.260318,"twenty":-14.588672,"median":-10.413035,"eighty":-8.668829,"marketCap":586176919},{"date":"2025-07-11","current":-8.284756,"twenty":-14.14074,"median":-9.690076,"eighty":-8.535817,"marketCap":587911170},{"date":"2025-07-18","current":-8.043423,"twenty":-13.87507,"median":-9.628891,"eighty":-8.433029,"marketCap":570785439},{"date":"2025-07-25","current":-8.816301,"twenty":-13.38389,"median":-9.506697,"eighty":-8.433029,"marketCap":625631134},{"date":"2025-08-01","current":-10.285126,"twenty":-12.797445,"median":-9.491423,"eighty":-8.48456,"marketCap":729863398},{"date":"2025-08-08","current":-9.243749,"twenty":-12.637058,"median":-9.506697,"eighty":-8.519369,"marketCap":655964186},{"date":"2025-08-15","current":-10.23612,"twenty":-12.367549,"median":-9.430326,"eighty":-8.524348,"marketCap":726385788},{"date":"2025-08-22","current":-10.346383,"twenty":-12.210773,"median":-9.506697,"eighty":-8.53478,"marketCap":734210411},{"date":"2025-08-29","current":-11.461269,"twenty":-12.163662,"median":-9.628891,"eighty":-8.548511,"marketCap":813326038},{"date":"2025-09-05","current":-12.312748,"twenty":-12.179108,"median":-9.681286,"eighty":-8.567484,"marketCap":873749512},{"date":"2025-09-12","current":-15.522638,"twenty":-12.446687,"median":-9.727683,"eighty":-8.641901,"marketCap":1101532967},{"date":"2025-09-19","current":-13.656808,"twenty":-13.735035,"median":-10.052347,"eighty":-8.661432,"marketCap":1001986381},{"date":"2025-09-26","current":-13.111721,"twenty":-13.639034,"median":-10.266749,"eighty":-8.666193,"marketCap":961993866},{"date":"2025-10-03","current":-12.140044,"twenty":-13.564381,"median":-10.319662,"eighty":-8.681485,"marketCap":890702861},{"date":"2025-10-10","current":-13.17097,"twenty":-13.533571,"median":-10.444395,"eighty":-8.70255,"marketCap":966340878},{"date":"2025-10-17","current":-12.222992,"twenty":-13.435219,"median":-10.631231,"eighty":-8.716023,"marketCap":896788678},{"date":"2025-10-24","current":-11.858613,"twenty":-13.293022,"median":-10.863051,"eighty":-8.739096,"marketCap":870054551},{"date":"2025-10-31","current":-15.145803,"twenty":-13.564381,"median":-11.055506,"eighty":-8.749568,"marketCap":1178979618},{"date":"2025-11-07","current":-14.161722,"twenty":-13.91523,"median":-11.228491,"eighty":-8.756685,"marketCap":1102376760},{"date":"2025-11-14","current":-14.840399,"twenty":-14.167423,"median":-11.440151,"eighty":-8.762559,"marketCap":1155206317},{"date":"2025-11-21","current":-16.062017,"twenty":-14.833302,"median":-11.540904,"eighty":-8.774755,"marketCap":1250299520},{"date":"2025-11-28","current":-17.724775,"twenty":-15.145803,"median":-11.576718,"eighty":-8.779642,"marketCap":1379731935},{"date":"2025-12-05","current":-16.966919,"twenty":-15.332439,"median":-11.635852,"eighty":-8.816301,"marketCap":1320738930},{"date":"2025-12-12","current":-16.57668,"twenty":-15.394651,"median":-11.66167,"eighty":-8.816301,"marketCap":1290361934},{"date":"2025-12-19","current":-16.435289,"twenty":-15.547354,"median":-11.719728,"eighty":-8.816301,"marketCap":1279355776},{"date":"2025-12-26","current":-17.583384,"twenty":-15.759893,"median":-11.773049,"eighty":-8.818649,"marketCap":1368725777},{"date":"2026-01-02","current":-17.232734,"twenty":-15.960216,"median":-11.858773,"eighty":-8.819236,"marketCap":1341430506},{"date":"2026-01-09","current":-18.092392,"twenty":-16.141928,"median":-11.883371,"eighty":-8.865131,"marketCap":1408347945},{"date":"2026-01-16","current":-10.061383,"twenty":-16.097911,"median":-11.858773,"eighty":-8.897333,"marketCap":783198185},{"date":"2026-01-23","current":-9.334633,"twenty":-16.07559,"median":-11.773049,"eighty":-8.931179,"marketCap":726626534},{"date":"2026-01-30","current":-8.364691,"twenty":-16.041657,"median":-11.675641,"eighty":-8.819236,"marketCap":651124292},{"date":"2026-02-06","current":-7.488067,"twenty":-15.977182,"median":-11.659491,"eighty":-8.794306,"marketCap":582886114}],"updateTime":1770672243044},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610372946","title":"UBS Initiates Coverage on Beta Bionics With Buy Rating, $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2610372946","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610372946?lang=en_us&edition=fundamental","pubTime":"2026-02-09 20:14","pubTimestamp":1770639291,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. (BBNX) has an average rating of overweight and mean price target of $28.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2610531508","title":"Beta Bionics initiated with a Buy at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2610531508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610531508?lang=en_us&edition=fundamental","pubTime":"2026-02-09 05:15","pubTimestamp":1770585305,"startTime":"0","endTime":"0","summary":"UBS initiated coverage of Beta Bionics (BBNX) with a Buy rating and $24 price target Published first on TheFly – the ultimate source for real-time,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-ubs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU1829250122.USD","LU1863844749.USD","BK4588","BBNX","BK4118","IE0034235071.USD","LU3187612489.SGD","BK4082","UBS","BK4585","LU1863844665.USD"],"gpt_icon":0},{"id":"2608362578","title":"Beta Bionics Is Maintained at Buy by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362578","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608362578?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:27","pubTimestamp":1770211620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2026 08:27 ET (13:27 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","SF"],"gpt_icon":0},{"id":"2608614330","title":"U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico","url":"https://stock-news.laohu8.com/highlight/detail?id=2608614330","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608614330?lang=en_us&edition=fundamental","pubTime":"2026-02-04 14:59","pubTimestamp":1770188350,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, PepsicoFeb 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ametek, Coca-Cola","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL8N3Z00I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZO","DOCS","EPD","BKNG","BC","BHE","CSGP","BRBR","CHD","EMR","AMDW","AMAT","PEP","AES","DY","BR","BALL","AXP","AMGN","KO","AMDU","BBNX","CLX","CRUS","ABNB","AMUU","ATI","ONC","DOX","EMN","AMDG","CCI","AME","BKR","AMYY","COLM","NET","AMDL","CMG","AMDD","CTMX","DVA","ADM","ARCB","DVN","AMD","AMDY","APPN","AMR","ASH"],"gpt_icon":1},{"id":"2608489889","title":"Lake Street Sticks to Their Buy Rating for Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608489889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608489889?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:57","pubTimestamp":1770044227,"startTime":"0","endTime":"0","summary":"In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Beta Bionics, Inc., with a price target of $40.00. According...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-their-buy-rating-for-beta-bionics-inc-bbnx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-sticks-to-their-buy-rating-for-beta-bionics-inc-bbnx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2608075860","title":"Balanced Risk-Reward Amid FDA Warning Letter Keeps Beta Bionics at Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2608075860","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608075860?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:56","pubTimestamp":1770044188,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Mathew Blackman has maintained their neutral stance on BBNX stock, giving a Hold rating on January 31. Mathew Blackman has given h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/balanced-risk-reward-amid-fda-warning-letter-keeps-beta-bionics-at-hold-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/balanced-risk-reward-amid-fda-warning-letter-keeps-beta-bionics-at-hold-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2608988178","title":"Beta Bionics discloses FDA warning letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2608988178","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608988178?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:55","pubTimestamp":1770044134,"startTime":"0","endTime":"0","summary":"In a regulatory 8-K filing on Friday, the company stated: “On January 29, 2026, Beta Bionics (BBNX) received a warning letter from the U.S. Food an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-discloses-fda-warning-letter-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-discloses-fda-warning-letter-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2608860009","title":"Beta Bionics price target lowered to $25 from $37 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2608860009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608860009?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:55","pubTimestamp":1770044121,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Beta Bionics (BBNX) to $25 from $37 but keeps a Buy rating on the shares after the company disclosed FDA ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-25-from-37-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-25-from-37-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2608867395","title":"Beta Bionics Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2608867395","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608867395?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:14","pubTimestamp":1770041640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 02, 2026 09:14 ET (14:14 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2608425863","title":"Truist Trims Price Target on Beta Bionics to $25 From $37, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2608425863","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608425863?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:32","pubTimestamp":1770031952,"startTime":"0","endTime":"0","summary":"Beta Bionics (BBNX) has an average rating of overweight and mean price target of $29.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2608618856","title":"U.S. RESEARCH ROUNDUP-Air Products, Chevron, UnitedHealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2608618856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608618856?lang=en_us&edition=fundamental","pubTime":"2026-02-02 16:05","pubTimestamp":1770019550,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Air Products, Chevron, UnitedHealthFeb 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Air Produ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nL8N3YY0FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOOGL","GOOY","CL","ASTH","CSW","CCB","CAT","CFR","BX","AMP","CF","CHTR","DAMD","GOOP","BBY","ARCB","AMDU","CHD","GGLS","ABCB","BA","BXP","DOW","HSY","ACAD","BC","EMN","AMD","AMAT","ABT","BBNX","DOV","CVX","DECK","EXP","BTSG","ELV","EGBN","AWK","DNTH","ARE","BKU","GOOX","AXP","GOOW","GOU","APD","GGLL","ADSK","BKR"],"gpt_icon":0},{"id":"2607302177","title":"Beta Bionics Inc - Warning Letter Does Not Restrict Production or FDA Clearance - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607302177","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607302177?lang=en_us&edition=fundamental","pubTime":"2026-01-31 05:32","pubTimestamp":1769808745,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nFWN3YV12P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2607217440","title":"FDA Issues Warning Letter to Beta Bionics Over Quality System Deficiencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2607217440","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607217440?lang=en_us&edition=fundamental","pubTime":"2026-01-31 05:30","pubTimestamp":1769808658,"startTime":"0","endTime":"0","summary":"Beta Bionics Inc. has received a warning letter from the U.S. Food and Drug Administration  following an inspection of its Irvine, California facility in June 2025. The FDA cited deficiencies in the company's Quality Management System, Medical Device Reporting, and Correction and Removals, which were previously communicated through a Form 483. While the warning letter does not currently restrict Beta Bionics' ability to produce, market, or seek FDA clearance for new products, the company must address the cited non-conformities to the FDA’s satisfaction to avoid potential further legal or regulatory action. Beta Bionics has initiated corrective actions and is preparing a written response, but cannot guarantee when the issues will be resolved. The company does not expect the warning letter to materially impact its planned commercialization of Mint by the end of 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL3W9X28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2606782288","title":"Beta Bionics Initiated at Hold by TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2606782288","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606782288?lang=en_us&edition=fundamental","pubTime":"2026-01-27 21:27","pubTimestamp":1769520420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2026 08:27 ET (13:27 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BBNX","BK4566","COWN","BK4585","BK4207","BK4082","TD"],"gpt_icon":0},{"id":"2606218781","title":"TD Cowen Initiates Beta Bionics at Hold WIth Price Target $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2606218781","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606218781?lang=en_us&edition=fundamental","pubTime":"2026-01-27 20:40","pubTimestamp":1769517657,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. (BBNX) has an average rating of overweight and mean price target of $30.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX","TD","COWN"],"gpt_icon":0},{"id":"2606206678","title":"U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2606206678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606206678?lang=en_us&edition=fundamental","pubTime":"2026-01-27 15:49","pubTimestamp":1769500141,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet HoldingsJan 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AMET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nL8N3YS0HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BY","LU1935042991.SGD","CVNA","ATEC","CVS","CAH","BKH","CIFR","COF","AME","ABBV","AFRM","LU1880398554.USD","CRWU","USAW.SI","CORZ","BAM","CTVA","BRO","LU1153585028.USD","CRWV","DHI","AEYE","CAT","SG9999014898.SGD","COHR","ATO","LU1291159041.SGD","ARDX","BOH","BMY","ABOS","CWAN","APH","ASGN","CHRD","DDOG","BIIB","CORD","CRWG","BBNX","CSGP","AA","BKR","AMZN","APEI","IE00BGHQF631.EUR","CRGY","CWVX","BIOA"],"gpt_icon":0},{"id":"2603935949","title":"Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2603935949","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603935949?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:03","pubTimestamp":1768510980,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Jan.  15, 2026  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/15/3219981/0/en/Beta-Bionics-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-17-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2603760109","title":"Beta Bionics price target lowered to $25 from $33 at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2603760109","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603760109?lang=en_us&edition=fundamental","pubTime":"2026-01-15 19:36","pubTimestamp":1768476977,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst David Roman lowered the firm’s price target on Beta Bionics (BBNX) to $25 from $33 and keeps a Buy rating on the shares. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-25-from-33-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-25-from-33-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0},{"id":"2602305265","title":"Beta Bionics Slides After Preliminary Key Indicator Falls Short","url":"https://stock-news.laohu8.com/highlight/detail?id=2602305265","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602305265?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:06","pubTimestamp":1767985560,"startTime":"0","endTime":"0","summary":"Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations.The stock slipped 36%, to $20.5, on Friday. Over the past three months, shares are still up 4%.Beta Bionics said Thursday it expects at least 5,581 new patient starts in the fiscal fourth quarter, which was below the 5,816 expected by Wall Street, according to Bank of America analysts led by Travis Steed.The analysts downgraded the stock to \"neutral\" from \"buy\" following the report about new patient starts, which is a leading indicator for Beta Bionics. The price outlook was also cut to $28 a share from $33.Given Beta Bionics' relatively small market share of about 1% to 2%, investors were looking for more momentum in new patient starts, Steed said in a note.\"The market is increasingly competitive and BBNX is going to have to prove its ability to execute against larger/more scaled competitors,\" Steed said.Beta Bionics' preliminary revenue o","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2602087053","title":"Crude Oil Rises Sharply; US Consumer Sentiment Edges Higher In January","url":"https://stock-news.laohu8.com/highlight/detail?id=2602087053","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602087053?lang=en_us&edition=fundamental","pubTime":"2026-01-10 01:21","pubTimestamp":1767979285,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/49818860/crude-oil-rises-sharply-us-consumer-sentiment-edges-higher-in-january","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","SQQQ","BK4139","ANPA","BK4087","QID","CGON","TQQQ","QTRX","USAW.SI","BK4082","AQST","BBNX","USJW.SI","BK4007","TSYW.SI","PCRX","QLD","NQmain","BK4121","NVIW.SI","PSQ",".IXIC"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}]}}